American Red Cross


The Cell & Gene Therapy Solutions division of the American Red Cross is a nationwide leader in the provision of autologous and allogeneic leukapheresis services for cell and gene therapy, supporting both clinical trial usage and commercial product manufacture. We currently perform autologous Mononuclear Cell collections at 62 Red Cross sites across the country and at multiple hospital locations. Our allogeneic Mononuclear Cell products are collected from healthy donors and are utilized by clients to support a broad range of applications, from bench research to use in clinical trials.